Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174746
Status:
COMPLETED
Last Update Posted:
2009-04-08
First Post:
2005-09-13
Brief Title:
Dose Response Study of Inhaled Ciclesonide Glucocorticosteroid to Patients With Persistent Asthma
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
A Placebo- and Active-Controlled Ciclesonide Metered-Dose Inhaler Randomized Parallel-Group Dose-Range Finding Study of Ciclesonide Administered by Dry Powder Inhaler Ultrahaler in Adult and Adolescent Patients With Persistent Asthma
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the efficacy and safety of ciclesonide inhaled into the lungs in a range of doses in a new dry powder inhaler compared to ciclesonide inhaled into the lungs using a metered dose inhaler
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None